1.Love RM, Jenkinson HF. Invasion of dentinal tubules by oral bacteria. Crit Rev Oral Biol Med. 2002;13(2):171–183.
2.Loesche WJ. Microbiology of Dental Decay and Periodontal Disease. In: Baron S, ed. Medical Microbiology. 4th ed. Galveston (TX)1996.
3.Sundqvist G. Ecology of the root canal flora. J Endod. Sep 1992;18(9):427–430.
4.Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp–39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. Jul 15 1997;43(2):221–225.
5.Volck B, Price PA, Johansen JS, et al. YKL–40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians. Jul-Aug 1998;110(4):351–360.
6.Ringsholt M, Hogdall EV, Johansen JS, Price PA, Christensen LH. YKL–40 protein expression in normal adult human tissues—an immunohistochemical study. J Mol Histol. Mar 2007;38(1):33–43.
7.Fontana RJ, Dienstag JL, Bonkovsky HL, et al. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. Oct 2010;59(10):1401–1409.
8.Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL–40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev. Feb 2006;15(2):194–202.
9.Letuve S, Kozhich A, Arouche N, et al. YKL–40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol. Oct 1 2008;181(7):5167–5173.
10.Nielsen AR, Erikstrup C, Johansen JS, et al. Plasma YKL–40: a BMI-independent marker of type 2 diabetes. Diabetes. Nov 2008;57(11):3078–3082.
11.Turkyilmaz AK, Devrimsel G, Kirbas A, et al. Relationship between pulse wave velocity and serum YKL–40 level in patients with early rheumatoid arthritis. Rheumatol Int. Nov 2013;33(11):2751–2756.
12.Pezelj-Ribaric S, Anic I, Brekalo I, Miletic I, Hasan M, Simunovic-Soskic M. Detection of tumor necrosis factor alpha in normal and inflamed human dental pulps. Arch Med Res. Sep-Oct 2002;33(5):482–484.
13.D’Souza R, Brown LR, Newland JR, Levy BM, Lachman LB. Detection and characterization of interleukin–1 in human dental pulps. Arch Oral Biol. 1989;34(5):307–313.
14.Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL–6, but not TNF-alpha, increases plasma YKL–40 in human subjects. Cytokine. Jul 2011;55(1):152–155.
15.Vaananen T, Koskinen A, Paukkeri EL, et al. YKL–40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints. Mediators Inflamm. 2014;2014:215140.
16.Keles ZP, Keles GC, Avci B, Cetinkaya BO, Emingil G. Analysis of YKL–40 acute-phase protein and interleukin–6 levels in periodontal disease. J Periodontol. Sep 2014;85(9):1240–1246.
17.Silness J, Loe H. Periodontal Disease in Pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta odontologica Scandinavica. Feb 1964;22:121–135.
18.Loe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. Nov-Dec 1967;38(6):Suppl:610–616.
19.International Caries Detection and Assessment System (ICDAS) Coordinating Committee. Rationale and Evidence for the International Caries Detection and Assessment System (ICDAS II) [Internet] Scotland: Dental Health Services Research Unit; 2005. Available from: http://www.icdas.org..
20.Monse B, Heinrich-Weltzien R, Benzian H, Holmgren C, van Palenstein Helderman W. PUFA - An index of clinical consequences of untreated dental caries. Community Dent Oral Epidemiol. Feb 2010;38(1):77–82.
21.Kim JS, Kim KD, Na HS, et al. Tumor necrosis factor-α and interleukin–1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7. Molecular Oral Microbiology. 2012;27:149–159.
22.Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. Jun 2011;8(6):322–336.
23.Kojima A, Nakano K, Wada K, et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012;2:332.